Fresenius | FRE - Current Assets



Fresenius reported EUR10.88B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Akzo Nobel EUR 6.33B 194M Jun/2025
Alcon AG USD 6.31B 239M Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
BASF EUR 31.9B 1.29B Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Beiersdorf EUR 6.65B 212M Jun/2025
DaVita Healthcare Partners USD 4.09B 451.64M Jun/2025
Demant DKK 10.2B 282M Jun/2025
E.ON EUR 23.56B 2.63B Jun/2025
Essilor EUR 11.03B 991M Jun/2025
Fresenius EUR 10.88B 1.03B Jun/2025
Fresenius Medical Care EUR 8.14B 178.09M Jun/2025
Getinge SEK 18.16B 1.83B Dec/2024
Givaudan CHF 4.24B 629M Jun/2024
GlaxoSmithKline GBP 17.67B 412M Jun/2025
GN Store Nord DKK 8.99B 105M Jun/2025
GRIFOLS EUR 5.25B 393.8M Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.2B 216M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Philips EUR 9.06B 394M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
RWE EUR 29.81B 21M Jun/2025
Sanofi 37.02B 7B Jun/2025
Smith & Nephew USD 4.63B 206M Jun/2025